Joint Formulary & PAD

Atropine sulfate - Painful Ciliary Spasm in blind eyes

You are here : Home > Formulary Search > Atropine sulfate - Painful Ciliary Spasm in blind eyes

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Initiation by specialist. Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.

Documentation

Evidence Review
Atropine colour change application Sep-18

PAD Profile

ChemicalSubstance :
Atropine sulfate
Indication :
Painful Ciliary Spasm in blind eyes
Group Name :
Keywords :
Brand Names Include :
Minims
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

05 Sep 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of Atropine for the treatment of painful ciliary spasm in blind eyes

Atropine will be considered to be BLUE (no information sheet) on the traffic light system.

Initiation will be by consultant ophthalmologists and transfer of care can be considered after a minimum of 2 months prescribing by the consultant and once the patient has shown to be benefiting from treatment.

Other Indications

Below are listed other indications that Atropine sulfate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Painful Ciliary Spasm in blind eyes.

  • No records returned.